293 related articles for article (PubMed ID: 31128467)
1. A Cell-Permeant Mimetic of NMN Activates SARM1 to Produce Cyclic ADP-Ribose and Induce Non-apoptotic Cell Death.
Zhao ZY; Xie XJ; Li WH; Liu J; Chen Z; Zhang B; Li T; Li SL; Lu JG; Zhang L; Zhang LH; Xu Z; Lee HC; Zhao YJ
iScience; 2019 May; 15():452-466. PubMed ID: 31128467
[TBL] [Abstract][Full Text] [Related]
2. SARM1 is a metabolic sensor activated by an increased NMN/NAD
Figley MD; Gu W; Nanson JD; Shi Y; Sasaki Y; Cunnea K; Malde AK; Jia X; Luo Z; Saikot FK; Mosaiab T; Masic V; Holt S; Hartley-Tassell L; McGuinness HY; Manik MK; Bosanac T; Landsberg MJ; Kerry PS; Mobli M; Hughes RO; Milbrandt J; Kobe B; DiAntonio A; Ve T
Neuron; 2021 Apr; 109(7):1118-1136.e11. PubMed ID: 33657413
[TBL] [Abstract][Full Text] [Related]
3. Permeant fluorescent probes visualize the activation of SARM1 and uncover an anti-neurodegenerative drug candidate.
Li WH; Huang K; Cai Y; Wang QW; Zhu WJ; Hou YN; Wang S; Cao S; Zhao ZY; Xie XJ; Du Y; Lee CS; Lee HC; Zhang H; Zhao YJ
Elife; 2021 May; 10():. PubMed ID: 33944777
[TBL] [Abstract][Full Text] [Related]
4. A conformation-specific nanobody targeting the nicotinamide mononucleotide-activated state of SARM1.
Hou YN; Cai Y; Li WH; He WM; Zhao ZY; Zhu WJ; Wang Q; Mai X; Liu J; Lee HC; Stjepanovic G; Zhang H; Zhao YJ
Nat Commun; 2022 Dec; 13(1):7898. PubMed ID: 36550129
[TBL] [Abstract][Full Text] [Related]
5. Nicotinic acid mononucleotide is an allosteric SARM1 inhibitor promoting axonal protection.
Sasaki Y; Zhu J; Shi Y; Gu W; Kobe B; Ve T; DiAntonio A; Milbrandt J
Exp Neurol; 2021 Nov; 345():113842. PubMed ID: 34403688
[TBL] [Abstract][Full Text] [Related]
6. cADPR is a gene dosage-sensitive biomarker of SARM1 activity in healthy, compromised, and degenerating axons.
Sasaki Y; Engber TM; Hughes RO; Figley MD; Wu T; Bosanac T; Devraj R; Milbrandt J; Krauss R; DiAntonio A
Exp Neurol; 2020 Jul; 329():113252. PubMed ID: 32087251
[TBL] [Abstract][Full Text] [Related]
7. A phase transition reduces the threshold for nicotinamide mononucleotide-based activation of SARM1, an NAD(P) hydrolase, to physiologically relevant levels.
Icso JD; Thompson PR
J Biol Chem; 2023 Nov; 299(11):105284. PubMed ID: 37742918
[TBL] [Abstract][Full Text] [Related]
8. Acidic pH irreversibly activates the signaling enzyme SARM1.
Zhao YJ; He WM; Zhao ZY; Li WH; Wang QW; Hou YN; Tan Y; Zhang D
FEBS J; 2021 Dec; 288(23):6783-6794. PubMed ID: 34213829
[TBL] [Abstract][Full Text] [Related]
9. SARM1 is a multi-functional NAD(P)ase with prominent base exchange activity, all regulated bymultiple physiologically relevant NAD metabolites.
Angeletti C; Amici A; Gilley J; Loreto A; Trapanotto AG; Antoniou C; Merlini E; Coleman MP; Orsomando G
iScience; 2022 Feb; 25(2):103812. PubMed ID: 35198877
[TBL] [Abstract][Full Text] [Related]
10. Modulator and messenger functions of cyclic ADP-ribose in calcium signaling.
Lee HC
Recent Prog Horm Res; 1996; 51():355-88; discussion 389. PubMed ID: 8701086
[TBL] [Abstract][Full Text] [Related]
11. The transmembrane glycoprotein CD38 is a catalytically active transporter responsible for generation and influx of the second messenger cyclic ADP-ribose across membranes.
Franco L; Guida L; Bruzzone S; Zocchi E; Usai C; De Flora A
FASEB J; 1998 Nov; 12(14):1507-20. PubMed ID: 9806760
[TBL] [Abstract][Full Text] [Related]
12. Kinetic competence of the cADP-ribose-CD38 complex as an intermediate in the CD38/NAD+ glycohydrolase-catalysed reactions: implication for CD38 signalling.
Cakir-Kiefer C; Muller-Steffner H; Oppenheimer N; Schuber F
Biochem J; 2001 Sep; 358(Pt 2):399-406. PubMed ID: 11513738
[TBL] [Abstract][Full Text] [Related]
13. The reaction mechanism for CD38. A single intermediate is responsible for cyclization, hydrolysis, and base-exchange chemistries.
Sauve AA; Munshi C; Lee HC; Schramm VL
Biochemistry; 1998 Sep; 37(38):13239-49. PubMed ID: 9748331
[TBL] [Abstract][Full Text] [Related]
14. Structural and Mechanistic Regulation of the Pro-degenerative NAD Hydrolase SARM1.
Bratkowski M; Xie T; Thayer DA; Lad S; Mathur P; Yang YS; Danko G; Burdett TC; Danao J; Cantor A; Kozak JA; Brown SP; Bai X; Sambashivan S
Cell Rep; 2020 Aug; 32(5):107999. PubMed ID: 32755591
[TBL] [Abstract][Full Text] [Related]
15. Porcine CD38 exhibits prominent secondary NAD(+) cyclase activity.
Ting KY; Leung CF; Graeff RM; Lee HC; Hao Q; Kotaka M
Protein Sci; 2016 Mar; 25(3):650-61. PubMed ID: 26660500
[TBL] [Abstract][Full Text] [Related]
16. NMN: The NAD precursor at the intersection between axon degeneration and anti-ageing therapies.
Loreto A; Antoniou C; Merlini E; Gilley J; Coleman MP
Neurosci Res; 2023 Dec; 197():18-24. PubMed ID: 36657725
[TBL] [Abstract][Full Text] [Related]
17. Fluorescent analogs of cyclic ADP-ribose: synthesis, spectral characterization, and use.
Graeff RM; Walseth TF; Hill HK; Lee HC
Biochemistry; 1996 Jan; 35(2):379-86. PubMed ID: 8555207
[TBL] [Abstract][Full Text] [Related]
18. SARM1-specific motifs in the TIR domain enable NAD+ loss and regulate injury-induced SARM1 activation.
Summers DW; Gibson DA; DiAntonio A; Milbrandt J
Proc Natl Acad Sci U S A; 2016 Oct; 113(41):E6271-E6280. PubMed ID: 27671644
[TBL] [Abstract][Full Text] [Related]
19. NMNAT1 inhibits axon degeneration via blockade of SARM1-mediated NAD
Sasaki Y; Nakagawa T; Mao X; DiAntonio A; Milbrandt J
Elife; 2016 Oct; 5():. PubMed ID: 27735788
[TBL] [Abstract][Full Text] [Related]
20. Blocking NAD(+)/CD38/cADPR/Ca(2+) pathway in sepsis prevents organ damage.
Peng QY; Ai ML; Zhang LN; Zou Y; Ma XH; Ai YH
J Surg Res; 2016 Apr; 201(2):480-9. PubMed ID: 27020835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
